Research on mRNA vaccines is being explored for various applications, including cancer therapeutics and respiratory mucosal vaccines. Studies are examining the current landscape of mRNA vaccine clinical trials and the use of mRNA lipid nanoparticles for cell engineering. The technology is being reviewed and analyzed in the context of traditional vaccine development platforms and its potential future directions.